GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma
Mayo Clinic
Mayo Clinic
Roswell Park Cancer Institute
Mayo Clinic
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Stanford University
Northwestern University
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Emory University
Epitopoietic Research Corporation
Case Comprehensive Cancer Center
Alliance for Clinical Trials in Oncology
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jonsson Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Children's Oncology Group
Rush University Medical Center
Radiation Therapy Oncology Group
University of Maryland, Baltimore
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Duke University
Burzynski Research Institute
Brown University
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
Case Comprehensive Cancer Center
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Baylor College of Medicine
DNAtrix, Inc.
RTOG Foundation, Inc.
Duke University
Radiation Therapy Oncology Group
Radiation Therapy Oncology Group
Radiation Therapy Oncology Group
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
University of California, Davis
Canadian Cancer Trials Group
Northwestern University
Celldex Therapeutics
Northwestern University
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)